Classes
DEA Class; OTC
Common Brand Names; Humulin 70/30, Novolin 70/30
- Antidiabetics, Insulins
Description
A combination of regular insulin and intermediate-acting insulin (NPH insulin); fixed-ratio mixtures
Used for type 1 and type 2 diabetes mellitus
For type 2 diabetes, most commonly given twice daily
Indications
Indicated for the treatment of type 1 diabetes mellitus.
Contraindications
Hypoglycemia
Documented hypersensitivity reactions to product or excipients
Adverse Effects
Hypoglycemia
Insulin resistance
Lipodystrophy
Lipohypertrophy
Local allergic reaction
Hypokalemia
Localized cutaneous amyloidosis
Warnings
Never share pen between patients even if needle is changed
Intermediate-acting insulin, do not use for circumstances that require rapid-acting insulin
Caution with decreased insulin requirements (eg, diarrhea, nausea/vomiting, malabsorption, hypothyroidism, renal impairment, hepatic impairment)
Caution with increased insulin requirements (eg, fever, hyperthyroidism, trauma, infection, surgery)
Thiazolidinediones are peroxisome proliferator-activated receptor (PPAR)-gamma agonists and can cause dose-related fluid retention, particularly when used in combination with insulin; fluid retention may lead to or exacerbate heart failure, monitor for signs and symptoms of heart failure and treat accordingly and consider discontinuing thiazolidinediones
Hypoglycemia may be life-threatening; increase frequency of blood glucose monitoring with changes to: insulin dosage, co-administered glucose lowering medications, meal pattern, physical activity; in patients with renal or hepatic impairment; and in patients with hypoglycemia unawareness
Severe, life-threatening, generalized allergy, hypersensitivity, including anaphylaxis, can occur; discontinue therapy, monitor, and treat if indicated
Pregnancy and Lactation
Available data from published studies over decades have not established association with human insulin use during pregnancy and major birth defects, miscarriage or adverse maternal or fetal Outcomes
Available data from published literature suggests that exogenous human insulin products, are transferred into human milk
Maximum Dosage
How supplied
NPH, human insulin isophane rDNA origin/regular, human insulin rDNA origin
Insulin isophane human/insulin regular human
injectable suspension
- (70 units/30 units)/mL